LXRX Stock Summary

• Lexicon Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 5.69% of US listed stocks.
• LXRX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 2.61% of US stocks.
• As for revenue growth, note that LXRX's revenue has grown -56.39% over the past 12 months; that beats the revenue growth of just 2.92% of US companies in our set.
• Stocks that are quantitatively similar to LXRX, based on their financial statements, market capitalization, and price volatility, are REPH, ICPT, CERS, CY, and AAOI.
• LXRX's SEC filings can be seen here.. And to visit Lexicon Pharmaceuticals Inc's official web site, go to www.lexpharma.com.